261 related articles for article (PubMed ID: 28131897)
1. Long noncoding RNAs and sulforaphane: a target for chemoprevention and suppression of prostate cancer.
Beaver LM; Kuintzle R; Buchanan A; Wiley MW; Glasser ST; Wong CP; Johnson GS; Chang JH; Löhr CV; Williams DE; Dashwood RH; Hendrix DA; Ho E
J Nutr Biochem; 2017 Apr; 42():72-83. PubMed ID: 28131897
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention.
Beaver LM; Buchanan A; Sokolowski EI; Riscoe AN; Wong CP; Chang JH; Löhr CV; Williams DE; Dashwood RH; Ho E
Mol Nutr Food Res; 2014 Oct; 58(10):2001-13. PubMed ID: 25044704
[TBL] [Abstract][Full Text] [Related]
3. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.
Xu C; Shen G; Chen C; Gélinas C; Kong AN
Oncogene; 2005 Jun; 24(28):4486-95. PubMed ID: 15856023
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane Inhibits c-Myc-Mediated Prostate Cancer Stem-Like Traits.
Vyas AR; Moura MB; Hahm ER; Singh KB; Singh SV
J Cell Biochem; 2016 Nov; 117(11):2482-95. PubMed ID: 26990292
[TBL] [Abstract][Full Text] [Related]
5. Reversal of the Warburg phenomenon in chemoprevention of prostate cancer by sulforaphane.
Singh KB; Hahm ER; Alumkal JJ; Foley LM; Hitchens TK; Shiva SS; Parikh RA; Jacobs BL; Singh SV
Carcinogenesis; 2019 Dec; 40(12):1545-1556. PubMed ID: 31555797
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of prostate cancer by d,l-sulforaphane is augmented by pharmacological inhibition of autophagy.
Vyas AR; Hahm ER; Arlotti JA; Watkins S; Stolz DB; Desai D; Amin S; Singh SV
Cancer Res; 2013 Oct; 73(19):5985-95. PubMed ID: 23921360
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cells.
Pei Y; Wu B; Cao Q; Wu L; Yang G
Toxicol Appl Pharmacol; 2011 Dec; 257(3):420-8. PubMed ID: 22005276
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.
Clarke JD; Hsu A; Yu Z; Dashwood RH; Ho E
Mol Nutr Food Res; 2011 Jul; 55(7):999-1009. PubMed ID: 21374800
[TBL] [Abstract][Full Text] [Related]
9. Functional relevance of D,L-sulforaphane-mediated induction of vimentin and plasminogen activator inhibitor-1 in human prostate cancer cells.
Vyas AR; Singh SV
Eur J Nutr; 2014 Apr; 53(3):843-52. PubMed ID: 24092501
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 is a novel target of cancer chemopreventative isothiocyanates in prostate cancer cells.
Sakao K; Vyas AR; Chinni SR; Amjad AI; Parikh R; Singh SV
Cancer Prev Res (Phila); 2015 May; 8(5):365-74. PubMed ID: 25712054
[TBL] [Abstract][Full Text] [Related]
11. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention.
Wang L; Liu D; Ahmed T; Chung FL; Conaway C; Chiao JW
Int J Oncol; 2004 Jan; 24(1):187-92. PubMed ID: 14654956
[TBL] [Abstract][Full Text] [Related]
12. The Role of Lysosome-associated Membrane Protein 2 in Prostate Cancer Chemopreventive Mechanisms of Sulforaphane.
Hahm ER; Singh KB; Kim SH; Powolny AA; Singh SV
Cancer Prev Res (Phila); 2020 Aug; 13(8):661-672. PubMed ID: 32434809
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells.
Nair S; Barve A; Khor TO; Shen GX; Lin W; Chan JY; Cai L; Kong AN
Acta Pharmacol Sin; 2010 Sep; 31(9):1223-40. PubMed ID: 20729872
[TBL] [Abstract][Full Text] [Related]
15. Effects of sulforaphane and 3,3'-diindolylmethane on genome-wide promoter methylation in normal prostate epithelial cells and prostate cancer cells.
Wong CP; Hsu A; Buchanan A; Palomera-Sanchez Z; Beaver LM; Houseman EA; Williams DE; Dashwood RH; Ho E
PLoS One; 2014; 9(1):e86787. PubMed ID: 24466240
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells.
Chiao JW; Chung FL; Kancherla R; Ahmed T; Mittelman A; Conaway CC
Int J Oncol; 2002 Mar; 20(3):631-6. PubMed ID: 11836580
[TBL] [Abstract][Full Text] [Related]
17. Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cells.
Tian H; Zhou Y; Yang G; Geng Y; Wu S; Hu Y; Lin K; Wu W
Oncol Rep; 2016 Sep; 36(3):1361-8. PubMed ID: 27430422
[TBL] [Abstract][Full Text] [Related]
18. Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line.
Herman-Antosiewicz A; Xiao H; Lew KL; Singh SV
Mol Cancer Ther; 2007 May; 6(5):1673-81. PubMed ID: 17513615
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism.
Singh KB; Kim SH; Hahm ER; Pore SK; Jacobs BL; Singh SV
Carcinogenesis; 2018 May; 39(6):826-837. PubMed ID: 29668854
[TBL] [Abstract][Full Text] [Related]
20. D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1.
Choi S; Lew KL; Xiao H; Herman-Antosiewicz A; Xiao D; Brown CK; Singh SV
Carcinogenesis; 2007 Jan; 28(1):151-62. PubMed ID: 16920735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
